Robert Ewing
About Robert Ewing
Robert Ewing is the Sr. Manager II of Computer Systems Validation at Bristol Myers Squibb in Bothell, Washington, with over 25 years of experience in the field, particularly in cell therapy manufacturing.
Current Role at Bristol Myers Squibb
Robert Ewing is currently working as the Sr. Manager II in Computer Systems Validation at Bristol Myers Squibb. He operates out of Bothell, Washington, United States. In his current role, he is responsible for overseeing the validation efforts for computer systems specifically related to cell therapy manufacturing.
Past Roles at Bristol Myers Squibb
Before his current position, Robert Ewing served as the Sr. Manager of Computer Systems Validation at Bristol Myers Squibb in Seattle, Washington, for a year from 2021 to 2022. Prior to that, he held the role of Manager, CSV, from 2019 to 2021 in the Greater Seattle Area.
Previous Experience in Pharmaceutical and Biotechnology Industries
Robert Ewing boasts over 25 years of experience in Computer Systems Validation. He has held various significant roles in multiple companies, including Celgene, Juno Therapeutics, Inc., Genzyme, and Bayer HealthCare. His career started with roles at Immunex and eFunds, where he gained a foundation in project management and validation.
Career Highlights at Juno Therapeutics and Genzyme
Robert Ewing was a Validation Supervisor at Juno Therapeutics, Inc., from 2016 to 2018 and a Sr. Validation Engineer at the same company from 2015 to 2016. Before that, he served as a Validation Engineer III (CSV) at Genzyme from 2013 to 2015 and Validation Engineer II (CSV) from 2012 to 2013 in the Greater Seattle Area.
Early Career and Transition into Computer Systems Validation
Robert began his professional journey at eFunds, where he worked as a Project Manager for 5 years from 1995 to 2000. He transitioned into the field of Validation Engineering at Immunex, spending a significant 5 years as a Validation Contractor from 2000 to 2005. His subsequent roles included tenures at Bayer HealthCare and Berlex Laboratories Inc.